We sequenced specific exons of 16 cancer-related genes, including the most clinically relevant genes such as KRAS, NRAS, EGFR, BRAF, cKIT, as well as other targetable genes that are known to be somatically altered in solid cancers based on recent scientific and clinical literature. This evidence concerns the gene EGFR and cancer.